3Mon

What will

•

4

•

ThemenmitKopf@topicswithhead

3Mon

Good buy

•

1

•

Matze@spatzis

3Mon

@topicswithhead Why do you think that? Kind regards

••

ThemenmitKopf@topicswithhead

3Mon

@dividend_dynamo_824 you don't know yourself why you are in or how. Interesting sector in which you are also marketing with an interesting concept. Biosimmilar is simply a highly lucrative area if you do it right

••

Matze@spatzis

3Mon

@topicswithhead 😀 I already know why I'm in. I was just interested in your opinion ;)

••

ThemenmitKopf@topicswithhead

3Mon

@dividend_dynamo_824 is just very lucrative and in principle much simpler than the other concepts, which is why you hopefully also get better and safer margins. But there are also other interesting providers, such as Sandoz. Why did you go in?

••

Matze@spatzis

3Mon

@topicswithhead An important approval for a biosimilar candidate is expected in mid-January. So it could continue to go up. Besides, you already said that the sector is simply very interesting 👍🏼

••

Novius@Novius

1Mon

Hmmh, now the share price looks different. What do the people invested here think?

••

Matze@spatzis

1Mon

Got out with a profit a few weeks ago. Fortunately

••

ThemenmitKopf@topicswithhead

1Mon

@Novius stay invested Little has changed in my thesis, regardless of that I can't tell you now whether it's a bargain or not. It seems that more companies are entering the market than planned. Probably all want to cut profits

••

Novius@Novius

1Mon

@topicswithhead am currently at -52%. I'm thinking about buying more "cheaply"

••

ThemenmitKopf@topicswithhead

1Mon

@Novius It depends on how much they make up of your portfolio. I have too much Germany and want to halve a few stocks before I buy more. If it is still at the price, I would buy a small position. However, I also have Amgen as a biosimmilar candidate and I'm also looking at Sandoz.

••

Matze@spatzis

2Mon

Will be something

••

Matze@spatzis

1Mon

📉

••